The impact of COVID-19 across health services, including treatment services for people who use drugs, is emerging but likely to have a high impact. Treatment services for people who use drugs provide essential treatment services including opiate agonist treatment and needle syringe programmes alongside other important treatment programmes across all substance types including withdrawal and counselling services. Drug and alcohol hospital consultation-liaison clinicians support emergency departments and other services provided in hospital settings in efficiently managing patients who use drugs and present with other health problems.COVID-19 will impact on staff availability for work due to illness. Patients may require home isolation and quarantine periods. Ensuring ongoing supply of opiate treatment during these periods will require significant changes to how treatment is provided. The use of monthly depot buprenorphine as well as moving from a framework of supervised dosing will be required for patients on sublingual buprenorphine and methadone. Ensuring ready access to take-home naloxone for patients is crucial to reduce overdose risks. Delivery of methadone and buprenorphine to the homes of people with confirmed COVID-19 infections is likely to need to occur to support home isolation.People who use drugs are likely to be more vulnerable during the COVID-19 epidemic, due to poorer health literacy and stigma and discrimination towards this group. People who use drugs may prioritise drug use above other health concerns. Adequate supply of clean injecting equipment is important to prevent outbreaks of blood-borne viruses. Opiate users may misinterpret SARS-CoV2 symptoms as opiate withdrawal and manage this by using opioids. Ensuring people who use drugs have access to drug treatment as well as access to screening and testing for SARS-CoV2 where this is indicated is important.

中文翻译：

---

在COVID-19大流行期间为吸毒者提供治疗服务方面面临的挑战。

COVID-19在医疗服务（包括为吸毒者提供的治疗服务）中的影响正在显现，但可能会产生很大影响。为使用毒品的人提供的治疗服务提供基本的治疗服务，包括鸦片激动剂治疗和针头注射器计划，以及涵盖所有药物类型的其他重要治疗计划，包括停药和咨询服务。毒品和酒精中毒医院咨询联络临床医生支持急诊部门和医院环境中提供的其他服务，以有效地管理使用药物和存在其他健康问题的患者.COVID-19将影响员工因疾病而上班的时间。患者可能需要在家隔离和隔离期。确保在这些期间持续提供阿片剂治疗将需要对治疗方式进行重大改变。舌下使用丁丙诺啡和美沙酮的患者将需要使用每月的丁丙诺啡仓库以及在有监督剂量的框架内使用。确保患者能随时获得带回家的纳洛酮对于减少用药过量的风险至关重要。为确诊COVID-19感染，可能需要将美沙酮和丁丙诺啡运送到家庭，以支持家庭隔离。由于较差的健康知识水平和对这个群体的污名和歧视。吸毒者可能会优先考虑其他健康问题。清洁注射设备的充足供应对于防止血源性病毒爆发很重要。阿片类药物使用者可能将SARS-CoV2症状误解为阿片类药物停药，并通过使用阿片类药物进行管理。确保使用毒品的人能够获得药物治疗以及在有此指示的情况下接受SARS-CoV2筛查和测试的重要性。